19h
ScienceAlert on MSNLung Cancer Is Rising in Non-Smokers, And This Could Be WhyWhile the number of smokers in the world as a proportion of the population is dropping, lung cancer continues to cause almost ...
Alabama's free radon test kits have proven to be a hot commodity, with 1,400 requests in a single day, leading to a temporary ...
Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at ...
A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...
Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
While Ideaya is letting Amgen go, it is retaining an interest in MAT2A-PRMT5 combinations. Ideaya has a PRMT5 inhibitor, ...
Blood clots form in response to signals from the lungs of cancer patients -- not from other organ sites, as previously thought -- according to a preclinical study. Clots are the second-leading cause ...
Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.
5d
The Brighterside of News on MSNBreakthrough new treatment could stop cancer from reaching the brainBrain metastases (BMs) are a devastating complication of cancer, occurring ten times more frequently than primary brain ...
NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.
COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results